{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-024936","form_type":"8-K","ticker":"CORT","cik":"0001088856","company_name":"CORCEPT THERAPEUTICS INC","filed_at":"2024-05-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.235606+00:00","generated_at":"2026-06-01T09:02:48.600681+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Corcept Therapeutics shareholders approve 2024 Incentive Award Plan adding 8M new shares","bullets":["2024 Plan replaces 2012 plan; total shares authorized = 8M new + 4,073,955 carryover + lapsed awards.","All 9 director nominees elected; vote range 56.9M to 65.6M for (excluding broker non-votes).","Ernst & Young ratified as auditor for FY2024: 86.6M for, 1.7M against.","Advisory say-on-pay approved: 64.5M for, 1.0M against; 22.5M broker non-votes.","2024 Plan passed with 47.0M for, 18.7M against; 22.5M broker non-votes."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-024936","json":"https://secwatch.observer/filing/0001628280-24-024936.json","markdown":"https://secwatch.observer/filing/0001628280-24-024936.md","text":"https://secwatch.observer/filing/0001628280-24-024936.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1088856/000162828024024936/0001628280-24-024936-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1088856/000162828024024936/cort-20240517.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T09:02:48.600681+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}